NIIMBL’s Viral Vector Program has awarded funding to Michigan Technological University to evaluate methods for detecting adeno-associated virus (AAV) aggregation in gene therapy manufacturing. The project will help the biopharmaceutical industry identify a reliable analytical method to support safe, cost-effective gene therapy production.
The...